Previous 10 | Next 10 |
Achieved fourth consecutive quarter of revenue growth with new high of $19.7 million, representing a 22.4% increase over the same period in 2022 Achieved $2.6 million in gross profit, representing a 425% increase over the same period in 2022 Continued to reduce expenses an...
2023-05-12 10:44:38 ET Major earnings expected before the bell on Monday include: Adamis Pharmaceuticals ( ADMP ) CV Sciences ( OTCQB:CVSI ) Sundial Growers ( SNDL ) Sunworks ( SUNW ) Workhorse Group ( WKHS ) For further details see: Notab...
2023-05-01 06:50:54 ET Healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers Rockwell Medical ( NASDAQ: RMTI ) enters a long-term supply agreement with Global Medical Supply Chain to begi...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that the Company expanded its geographic footprint by entering a long-term...
2023-04-28 18:00:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-04-27 09:13:12 ET Rockwell Medical ( NASDAQ: RMTI ) said its international partner, Drogsan Pharmaceuticals, had submitted a marketing authorization application and GMP application for Triferic AVNU to the Turkish Medicines and Medical Devices Agency. Triferic AVNU is a f...
Turkish Medicines and Medical Devices Agency assigns priority review status for Drogsan's Marketing Authorization application and high priority status for Drogsan's GMP application for Triferic AVNU Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that devel...
2023-04-19 02:45:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the first q...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company is exhibiting its hemodialysis concentrates portfolio in Booth ...
News, Short Squeeze, Breakout and More Instantly...
Rockwell Medical Inc. Company Name:
RMTI Stock Symbol:
NASDAQ Market:
Rockwell Medical Inc. Website:
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, announced that the Company's President and Chief Executive Officer, Dr. Mark Strobeck ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that it will release its financial and operational results for the second ...
Rockwell Medical, Inc. (the "Company") (Nasdaq: RMTI), a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products to dialysis providers worldwide, today announced that Tim Chole was promoted to Chief Commercial Officer, reporting to the ...